Cargando…

Mebendazole Mediates Proteasomal Degradation of GLI Transcription Factors in Acute Myeloid Leukemia

The prognosis of elderly AML patients is still poor due to chemotherapy resistance. The Hedgehog (HH) pathway is important for leukemic transformation because of aberrant activation of GLI transcription factors. MBZ is a well-tolerated anthelmintic that exhibits strong antitumor effects. Herein, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freisleben, Fabian, Modemann, Franziska, Muschhammer, Jana, Stamm, Hauke, Brauneck, Franziska, Krispien, Alexander, Bokemeyer, Carsten, Kirschner, Karl N., Wellbrock, Jasmin, Fiedler, Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508953/ https://www.ncbi.nlm.nih.gov/pubmed/34639011 http://dx.doi.org/10.3390/ijms221910670

Ejemplares similares

Downregulation of GLI3 Expression Mediates Chemotherapy Resistance in Acute Myeloid Leukemia
por: Freisleben, Fabian, et al.
Publicado: (2020)

The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemia
por: Wellbrock, Jasmin, et al.
Publicado: (2021)

Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemia
por: Latuske, Emily-Marie, et al.
Publicado: (2017)

Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells in vitro
por: Brauneck, Franziska, et al.
Publicado: (2023)

TIGIT blockade repolarizes AML-associated TIGIT(+) M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis
por: Brauneck, Franziska, et al.
Publicado: (2022)

Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma
por: Brauneck, Franziska, et al.
Publicado: (2021)

Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML
por: Brauneck, Franziska, et al.
Publicado: (2021)

The Actin Binding Protein Plastin-3 Is Involved in the Pathogenesis of Acute Myeloid Leukemia
por: Velthaus, Arne, et al.
Publicado: (2019)

Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian Cancer
por: Weimer, Pauline, et al.
Publicado: (2022)

A Comparative Outcome Analysis of COVID-19 and Influenza Infection in Patients with Hematological Malignancies
por: Ghandili, Susanne, et al.
Publicado: (2021)

COVID-19 and Adult Acute Leukemia: Our Knowledge in Progress
por: Modemann, Franziska, et al.
Publicado: (2022)

Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option
por: Stamm, Hauke, et al.
Publicado: (2018)

Acute Myeloid Leukemia and the Bone Marrow Niche—Take a Closer Look
por: Behrmann, Lena, et al.
Publicado: (2018)

Efficacy of Tigecycline as Salvage Therapy in Multidrug-Resistant Febrile Neutropenia in Patients with Acute Leukemia—A Single Center Analysis
por: Modemann, Franziska, et al.
Publicado: (2022)

hGFAP-mediated GLI2 overexpression leads to early death and severe cerebellar malformations with rare tumor formation
por: Niesen, Judith, et al.
Publicado: (2023)

Donor‐transmitted extramedullary acute myeloid leukaemia after living donor kidney transplantation
por: Ghandili, Susanne, et al.
Publicado: (2022)

Diagnostic Utility of Bronchoalveolar Lavage in Patients with Acute Leukemia under Broad-Spectrum Anti-Infective Treatment
por: Ghandili, Susanne, et al.
Publicado: (2022)

Dual degradation signals destruct GLI1: AMPK inhibits GLI1 through β-TrCP-mediated proteasome degradation
por: Zhang, Rui, et al.
Publicado: (2017)

The Clinical Significance of CD73 in Cancer
por: Bach, Niklas, et al.
Publicado: (2023)

Mebendazole for Differentiation Therapy of Acute Myeloid Leukemia Identified by a Lineage Maturation Index
por: Li, Yulin, et al.
Publicado: (2019)

Increased frequency of TIGIT(+)CD73-CD8(+) T cells with a TOX(+) TCF-1low profile in patients with newly diagnosed and relapsed AML
por: Brauneck, F., et al.
Publicado: (2021)

Mebendazole stimulates CD14+ myeloid cells to enhance T-cell activation and tumour cell killing
por: Rubin, Jenny, et al.
Publicado: (2018)

PGE2-JNK signaling axis non-canonically promotes Gli activation by protecting Gli2 from ubiquitin-proteasomal degradation
por: Yang, Jun, et al.
Publicado: (2021)

Clinical features of hepatitis E infections in patients with hematologic disorders
por: Ghandili, Susanne, et al.
Publicado: (2022)

Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway
por: Oliveira-Ferrer, Leticia, et al.
Publicado: (2013)

Overexpression of Gremlin-1 in Patients with Loeys-Dietz Syndrome: Implications on Pathophysiology and Early Disease Detection
por: Wellbrock, Jasmin, et al.
Publicado: (2014)

TGF-β Superfamily Receptors—Targets for Antiangiogenic Therapy?
por: Otten, Jasmin, et al.
Publicado: (2010)

Abdominal emergency surgery in patients with hematological malignancies: a retrospective single-center analysis
por: von Kroge, Philipp H., et al.
Publicado: (2023)

Treatment of echinococcosis: albendazole and mebendazole – what else?
por: Hemphill, Andrew, et al.
Publicado: (2014)

Efficacy and reinfection with soil-transmitted helminths 18-weeks post-treatment with albendazole-ivermectin, albendazole-mebendazole, albendazole-oxantel pamoate and mebendazole
por: Speich, Benjamin, et al.
Publicado: (2016)

Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
por: Nygren, Peter, et al.
Publicado: (2013)

Efficacy of Albendazole and Mebendazole With or Without Levamisole for Ascariasis and Trichuriasis
por: Anto, Endy Juli, et al.
Publicado: (2019)

Preventative Effect of Mebendazole against Malignancies in Neurofibromatosis 1
por: Staedtke, Verena, et al.
Publicado: (2020)

Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma
por: Li, Qian, et al.
Publicado: (2022)

Behavior of Mebendazole during NF/RO Adsorption and Photolysis
por: Babić, Bruna, et al.
Publicado: (2022)

Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients
por: Ghandili, Susanne, et al.
Publicado: (2020)

Anticancer potential of mebendazole against chronic myeloid leukemia: in silico and in vitro studies revealed new insights about the mechanism of action
por: Daniel, Julio Paulino, et al.
Publicado: (2022)

Mebendazole Is a Potential Alternative in the Treatment of Giardia duodenalis Infection
por: Cañete, Roberto
Publicado: (2016)

Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update
por: Chai, Jong-Yil, et al.
Publicado: (2021)

The ubiquitin-like modifier FAT10 is degraded by the 20S proteasome in vitro but not in cellulo
por: Oliveri, Franziska, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nd3kac635r504l42ictutss8g1